LifeScience Biologics
CARsgen's CT041 receives IND clearance from NMPA for pancreatic cancer therapy.
Dr Raffaele Baffa, Chief Medical Officer of CARsgen, commented that "We are glad to receive the IND clearance from NMPA for the adjuvant treatment of ...
April 20, 2023 | News
Samyang Holdings partners with LG Chem for innovative cancer therapeutics.
Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement on Thursday, April 20th, for development of nove...
April 20, 2023 | News
Lambda Therapeutics partners with Medidata to streamline clinical trial data management
Medidata, a Dassault Systèmes company, announced that Lambda Therapeutics is implementing Medidata's cloud-based clinical solutions – Rave EDC...
April 20, 2023 | News
Cytiva boosts process efficiency with X-platform bioreactors.
Global biotechnology leader builds on Xcellerex heritage to now offer X-platform bioreactors. X-platform bioreactors can be used for monoclonal antibodi...
April 19, 2023 | News
Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses
"This collaboration represents an exciting opportunity for Nona Biosciences to leverage its fully human antibody H2L2 transgenic mice, together with the te...
April 19, 2023 | News
BioSenic Granted Key European Patent for Therapeutic Development in Cancer and Immune Diseases
BioSenic’s new formulation lowers the dosage of arsenic trioxide by combining it with copper salts to ma...
April 18, 2023 | News
Shanghai Biopharma Presents Phase I Data for Novel CAR-T in Advanced Liver Cancer
Early results indicate that C-CAR031 is well tolerated with promising anti-tumor activity seen and objective responses in several patients to date, includi...
April 18, 2023 | News
Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees and Opens Spring 2023 Submissions
In support of global initiatives to advance molecular profiling in oncology, Thermo Fisher Scientific today announced the latest recipients of the&nb...
April 17, 2023 | News
Scientists from Singapore and Sweden achieve promising results towards restoring vision in blindness caused by cellular degeneration in the eye
A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplanting th...
April 17, 2023 | News
FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab)
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted for...
April 17, 2023 | News
AffaMed Therapeutics Approved for Phase 3 Trial of DEXTENZA® in China for Eye Surgery Inflammation and Pain
In addition, AffaMed is pleased to announce that DEXTENZA has recently been approved in Macau, China for the treatment of ocular itchin...
April 17, 2023 | News
Anika Enters Into Cooperation Agreement with Caligan Partners
As part of the agreement, the Company appointed Gary Fischetti as a Class III director. Fischetti will join two existing board members on a newly formed Ca...
April 14, 2023 | News
Evonik wins Asia-Pacific Bioprocessing Excellence Award for Cell Culture Solutions
The Asia-Pacific Bioprocessing Excellence Awards celebrate the latest biopharmaceutical technologies Evonik recognized for high-quality Cell Culture Sol...
April 13, 2023 | News
Discovery Life Sciences Acquiert Reachbio Research Labs
Discovery Life Sciences™ (Discovery), Biospecimen and Biomarker Specialists, has acquired Seattle-based ReachBio Research L...
April 12, 2023 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
